ETO interacting proteins
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The 8;21 translocation produces a fusion between the ETO gene and that encoding the myeloid transcription factor AML1. The AML1-ETO fusion substitutes the majority of the ETO protein for the coregulator recruitment domains of AML1. Biochemical analyses of ETO have led to the identification of numerous interacting proteins including many corepressors. Importantly, the proteins interacting with ETO are different from those of wild-type AML1, suggesting that altered coregulator recruitment underlies the oncogenic properties of AML1-ETO. The list of corepressors capable of binding ETO includes histone deacetylases (HDACs) and components of distinct HDAC core complexes. These investigations have provided mechanistic insight into corepressor recruitment by ETO and clues to the leukemogenic activity of AML1-ETO.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“but their selectivity profiles extended well beyond these isoforms as reported previously (12, 13, 26, 29, 30, 38).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [13]
Citations
Cites
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230 · cited 1×
“For example, NCoR and SMRT are capable of interacting with Sin3, and this interaction could be facilitated by ETO (Li et al., 1997; Nagy et al., 1997; Soderstrom et al., 1997).”
BackgroundZhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103 · cited 4×
“Purification of the Sin3 complex identified the cooperating components as HDAC1, HDAC2, Sin3-associated proteins 18 and 30 (SAP 18 and 30), and Rb-associated proteins 46 and 48 (RbAp46 and 48) (Zhang et al., 1997, 1998, 1999).”
BackgroundInfluentialXue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985 · cited 1×
“HDACs are the enzymatic components of multiprotein complexes such as the N-CoR, SMRT, and Sin3 complexes (Zhang et al., 1997, 1999, 2002; Xue et al., 1998; Guenther et al., 2000; Li et al., 2000; Wen et al., 2000; You et al., 2001; Humphrey et al., 2001; Yoon et al., 2003).”
BackgroundUbiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
Brooks, C. L., & Gu, W. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00003-6 · Cited by 742 · cited 1×
“Additionally, HDACs can act upon other transcription factors to control DNA binding, nuclear localization, or transcriptional activity (Hung et al., 1999, 2001; Brooks and Gu, 2003).”
BackgroundBoth corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3
Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J., & Wong, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4342 · Cited by 629 · cited 5×
“…for example, the functional dependence of ETO on HDAC3 would likely require a direct or indirect association with N-CoR or SMRT, because these proteins are essential for HDAC3’s histone deacetylase activity (Guenther et al., Oncogene 2000; Li et al., 2000; Zhang et al., 2002; Yoon et al., 2003).”
BackgroundInfluentialThe SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3
Guenther, M. G., Barak, O., & Lazar, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6091-6101.2001 · Cited by 611 · cited 1×
“HDAC3 is the putative enzymatic subunit of the complex and N-CoR or SMRT functions as an essential activating cofactor (Guenther et al., 2001).”
BackgroundSelf-citationHistone Deacetylases and SAP18, a Novel Polypeptide, Are Components of a Human Sin3 Complex
Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80216-0 · Cited by 578 · cited 4×
“Purification of the Sin3 complex identified the cooperating components as HDAC1, HDAC2, Sin3-associated proteins 18 and 30 (SAP 18 and 30), and Rb-associated proteins 46 and 48 (RbAp46 and 48) (Zhang et al., 1997, 1998, 1999).”
BackgroundInfluentialWang, J., Hoshino, T., Redner, R. L., Kajigaya, S., & Liu, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10860 · Cited by 512 · cited 8×
“Domains that disrupt interactions between ETO and HDAC complexes also disrupt ETO-mediated repression, consistent with HDACs being critical effectors of ETO (Gelmetti et al., 1998; Lutterbach et al., 1998b; Wang et al., 1998; Hildebrand et al., 2001).”
BackgroundMethodInfluentialCoREST is an integral component of the CoREST- human histone deacetylase complex
You, A., Tong, J. K., Grozinger, C. M., & Schreiber, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1454 · Cited by 502 · cited 1×
“HDACs are the enzymatic components of multiprotein complexes such as the N-CoR, SMRT, and Sin3 complexes (Zhang et al., 1997, 1999, 2002; Xue et al., 1998; Guenther et al., 2000; Li et al., 2000; Wen et al., 2000; You et al., 2001; Humphrey et al., 2001; Yoon et al., 2003).”
BackgroundMiyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., & Ohki, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05933.x · Cited by 498 · cited 3×
“Indeed, the protein’s name is an acronym for the translocation (Eight Twenty-One) (Miyoshi et al., 1993).”
Background
Cited by
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
Lauffer, B. E. L., Mintzer, R., Fong, R., Mukund, S., Tam, C., Zilberleyb, I., Flicke, B., Ritscher, A., Fedorowicz, G., Vallero, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.490706 · Cited by 429
Lamprecht, B., Walter, K., Kreher, S., Kumar, R., Hummel, M., Lenze, D., Köchert, K., Bouhlel, M. A., Richter, J., Soler, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2129 · Cited by 376
“Although we observed no obvious alteration in the protein expression of the corepressors of N-CoR, SIN3A and SIN3B, the histone deacetylases HDAC1, HDAC2 and HDAC3, the lymphoid-specific helicase or the DNA methyltransferases DNMT1 and DNMT3 (data not shown), we identified an HRS cell–specific loss of the ETO family m…”
BackgroundE Protein Silencing by the Leukemogenic AML1-ETO Fusion Protein
Zhang, J., Kalkum, M., Yamamura, S., Chait, B. T., & Roeder, R. G. (2004) · Science · doi:10.1126/science.1097937 · Cited by 213
Metadata
- Authors
- Hug, B. A., & Lazar, M. A.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Hug, Bruce A
- Lazar, Mitchell A
- Venue
- Oncogene
- Published
- 2004-05-24
- Volume
- 23
- Issue
- 24
- Pages
- 4270-4274
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2020677165
- Cited by
- 112
- References
- 47
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 7 · 2019: 6 · 2018: 1 · 2017: 4 · 2016: 6 · 2015: 6 · 2014: 9 · 2013: 7 · 2012: 8
- FWCI
- 0.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl004339-03)
- National Heart, Lung, and Blood Institute (HL004339)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK43806, R01DK045586, DK 45586)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- ETO, AML1-ETO fusion, 21 translocation, corepressors, coregulator recruitment, histone deacetylase, protein-protein interaction, leukemogenesis
- MeSH terms
- RUNX1 Translocation Partner 1 Protein, DNA-Binding Proteins, Histone Deacetylases, Humans, Nuclear Proteins, Repressor Proteins, Transcription Factors, Oncogene Proteins, Fusion, Protein Structure, Tertiary, Core Binding Factor Alpha 2 Subunit, Sin3 Histone Deacetylase and Corepressor Complex, Nuclear Receptor Co-Repressor 1, Nuclear Receptor Co-Repressor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ETO interacting proteins. https://app.cochat.ai/papers/10.1038/sj.onc.1207674
- The paper
- Hug, B. A., & Lazar, M. A. (2004). ETO interacting proteins. Oncogene. https://doi.org/10.1038/sj.onc.1207674
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.